Sara Dall'Armellina

6PUBLICATIONS
18CO-AUTHORS
Liquid biopsiesDigital processor architecturesCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2025
Synergizing Liquid Biopsy and Hybrid PET Imaging for Prognostic Assessment in Prostate Cancer: A Focus Review.

Federica Stracuzzi, Sara Dall' Armellina, Gayane Aghakhanyan

|Dec 09, 2023
Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment.

Guido Rovera, Serena Grimaldi, Sara Dall'Armellina

|Feb 11, 2023
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review.

Alessio Rizzo, Manuela Racca, Sara Dall'Armellina

|Jan 21, 2023
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review.

Alessio Rizzo, Manuela Racca, Sara Dall'Armellina

|Aug 26, 2022
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?

Alessio Rizzo, Sara Dall'Armellina, Daniele Antonio Pizzuto

|Jun 24, 2022
Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence.

Guido Rovera, Serena Grimaldi, Sara Dall'Armellina

Pageof 1

Frequent Collaborators

3 joint publications

Giorgio Treglia

2 joint publications

Francesco Dondi

2 joint publications

Roberto Passera

2 joint publications

Domenico Albano